anti glp 1 antibody Glutazumab, a novel long-lasting GLP-1/anti-GLP-1R fusion protein, exerts anti-diabetic effects through targeting dual receptor binding sites ICC/IF and reacts with Human samples Anti-GLP-1 antibody [EPR4042-407] (ab111125) |
Pay in 4 interest-free payments of $5.28 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
![anti glp 1 antibody Glutazumab, a novel long-lasting GLP-1/anti-GLP-1R fusion protein, exerts anti-diabetic effects through targeting dual receptor binding sites ICC/IF and reacts with Human samples Anti-GLP-1 antibody [EPR4042-407] (ab111125) |](https://content.abcam.com/products/images/glp-1-antibody-epr4042-407-ab111125--immunohistochemistry-formalin-pfa-fixed-paraffin-embedded-sections-img113733.jpg)
![anti glp 1 antibody Glutazumab, a novel long-lasting GLP-1/anti-GLP-1R fusion protein, exerts anti-diabetic effects through targeting dual receptor binding sites ICC/IF and reacts with Human samples Anti-GLP-1 antibody [EPR4042-407] (ab111125) |](https://content.abcam.com/products/images/glp-1-antibody-1b7b4-ab36598--immunohistochemistry-formalin-pfa-fixed-paraffin-embedded-sections-img108518.jpg)
![anti glp 1 antibody Glutazumab, a novel long-lasting GLP-1/anti-GLP-1R fusion protein, exerts anti-diabetic effects through targeting dual receptor binding sites ICC/IF and reacts with Human samples Anti-GLP-1 antibody [EPR4042-407] (ab111125) |](https://www.researchgate.net/publication/329348144/figure/fig2/AS:776893259337733@1562237195644/Stability-engineering-of-GLP-1-analogue-peptides-in-fusion-with-anti-PCSK9-Ab2-Human-Fc.jpg)
![anti glp 1 antibody Glutazumab, a novel long-lasting GLP-1/anti-GLP-1R fusion protein, exerts anti-diabetic effects through targeting dual receptor binding sites ICC/IF and reacts with Human samples Anti-GLP-1 antibody [EPR4042-407] (ab111125) |](https://content.abcam.com/products/images/glp-1-antibody-ab22625--immunohistochemistry-formalin-pfa-fixed-paraffin-embedded-sections-img102413.jpg)
![anti glp 1 antibody Glutazumab, a novel long-lasting GLP-1/anti-GLP-1R fusion protein, exerts anti-diabetic effects through targeting dual receptor binding sites ICC/IF and reacts with Human samples Anti-GLP-1 antibody [EPR4042-407] (ab111125) |](https://media.biocompare.com/m/37/images/ihc-immunohistchemistry-20381641-400x300.jpg)




















